Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neuboron Bio-scitech Co., Ltd.

Clinical trials sponsored by Neuboron Bio-scitech Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new radiation approach tackle recurrent head and neck cancer? Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can a new radiation approach tackle recurrent head and neck cancer?

Disease control Recruiting now

This phase II trial tests a new type of radiation therapy called accelerator-based boron neutron capture therapy (AB-BNCT) for people with head and neck cancer that has returned after prior treatment. The therapy combines a boron-containing drug (NBB-001) with a tracer (NBB-002) …

Phase 2 • Sponsor: Neuboron Bio-SciTech Co., Ltd. • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC